Puma Biotechnology (PBYI) Stock Insights

PBYI price $10.66 -0.26 -2.38%

Ticker
PBYI
Price
$10.66
Change
-0.26 -2.38%
Market cap ?
$550.27M
P/E ?
20.15
Forward P/E ?
28.05
Dividend yield ?
0.00%
Beta ?
1.21
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
45
Value
52
Quality
75
Growth
9

Stocklytics score rationale: value 52, quality 75, growth 9.

Financials

2016201720182019202020212022202320242025
027700000251000000272260000225110000253155000228031000235637000230468000228371000

Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications. These include patients with early-stage HER2-overexpressed/amplified breast cancer, as well as adults suffering from advanced or metastatic HER2-positive breast…

Fair value

PBYI fair value $10.85. Price $10.66. Price is about fair value.

Below fair value, but more expensive than usual. A smaller discount than on 85% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Average free cash flow, last three years 31.65M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.95% (beta 1.2). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 51.62M. Net debt -1.09M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare PBYI

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—0.09—57.50M
2026-08-060.190.0456.50M53.00M
2026-05-07-0.04-0.1344.80M42.00M
2026-02-260.290.2459.90M68.62M
2025-11-060.210.0951.90M51.00M
2025-08-070.150.1149.20M52.00M
2025-05-080.100.0243.10M44.55M
2025-02-270.430.1059.10M52.51M
2024-11-070.410.3580.50M70.65M
2024-08-01-0.05-0.1044.40M44.70M
2024-05-02-0.05-0.2243.80M41.05M
2024-02-290.260.3072.20M73.55M
2023-11-020.120.0856.10M57.95M
2023-08-030.050.0154.60M51.73M
2023-05-040.03-0.0752.80M49.63M
2023-03-02-0.120.0665.70M57.06M
2022-11-03-0.01-0.0757.10M50.47M
2022-08-040.210.0259.50M52.62M
2022-05-05-0.08-0.1745.70M45.07M
2022-03-030.10-0.0955.40M47.17M
2021-11-04-1.09-0.3146.24M55.06M
2021-08-05-0.13-0.2753.38M53.00M
2021-05-060.400.0998.17M69.96M
2021-02-25-0.38-0.3152.56M53.00M
2020-11-05-0.79-0.3950.75M36.69M
2020-08-060.08-0.3070.58M264.68M
2020-05-07-0.43-0.7751.22M91.71M
2020-02-20-0.29-0.4862.92M104.15M
2019-11-06-0.44-0.7156.40M90.93M
2019-08-08-0.97-0.9553.92M52.81M
2019-05-09-0.26-0.6899.10M259.10M
2019-02-28-0.80-0.7771.10M68.41M
2018-11-01-0.37-0.9762.60M164.19M
2018-08-09-1.17-1.2650.77M54.67M
2018-05-09-0.65-0.7566.52M102.33M
2018-03-01-1.71-1.9821.60M24.89M
2017-11-09-2.07-2.756.08M7.57M
2017-08-09-2.10-2.10——
2017-05-10-1.97-1.98——
2017-03-01-2.04-2.02——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-14WILSON TROY EDWARDSell5.00K$9.1045.50K
2026-09-14Cesano AlessandraBuy50.00K$2.93146.50K
2026-09-14Cesano AlessandraSell62.15K$9.12566.99K
2026-09-14Cesano AlessandraSell50.00K$2.93146.50K
2026-07-06AUERBACH ALAN HSell44.06K$8.26364.05K
2026-07-06HUNT DOUGLAS MSell8.46K$8.2669.90K
2026-07-06NOUGUES MAXIMO FSell9.39K$8.2677.56K
2026-06-12WILSON TROY EDWARDSell10.80K$7.2077.75K
2026-06-12Stuglik Brian MSell8.10K$7.2058.31K
2026-06-12Senderowicz AdrianSell27.00K$7.20194.31K
2026-06-12MOYES JAY MSell22.00K$7.22158.80K
2026-06-12Dorval AllisonSell11.61K$7.2083.58K
2026-06-11WILSON TROY EDWARDBuy27.00K——
2026-06-11Stuglik Brian MBuy27.00K——
2026-06-11Senderowicz AdrianBuy27.00K$7.20194.31K
2026-06-11MILLER MICHAEL PATRICKBuy27.00K——
2026-06-11MOYES JAY MBuy27.00K——
2026-06-11Dorval AllisonBuy27.00K——
2026-06-11Cesano AlessandraBuy27.00K——
2026-02-18AUERBACH ALAN HBuy159.78K——
2026-02-18AUERBACH ALAN HBuy227.47K$6.681.52M
2026-02-18HUNT DOUGLAS MBuy49.39K——
2026-02-18HUNT DOUGLAS MBuy70.32K$6.68469.74K
2026-02-18NOUGUES MAXIMO FBuy46.74K——
2026-02-18NOUGUES MAXIMO FBuy66.54K$6.68444.49K
2026-01-07AUERBACH ALAN HSell18.01K$5.88105.89K
2026-01-07HUNT DOUGLAS MSell5.01K$5.8829.48K
2026-01-07NOUGUES MAXIMO FSell6.41K$5.8837.65K
2026-01-06AUERBACH ALAN HSell16.94K$5.8498.99K
2026-01-06HUNT DOUGLAS MSell3.97K$5.8423.22K
2026-01-06NOUGUES MAXIMO FSell4.54K$5.8426.53K
2025-11-11MILLER MICHAEL PATRICKSell20.00K$4.8697.23K
2025-07-18Cesano AlessandraSell27.00K$3.3790.91K
2025-07-09NOUGUES MAXIMO FSell3.94K$3.5413.91K
2025-07-09HUNT DOUGLAS MSell3.44K$3.5412.17K
2025-07-09AUERBACH ALAN HSell21.58K$3.5476.29K
2025-07-08NOUGUES MAXIMO FSell5.59K$3.5319.74K
2025-07-08HUNT DOUGLAS MSell4.37K$3.5315.45K
2025-07-08AUERBACH ALAN HSell25.59K$3.5390.42K
2025-06-13WILSON TROY EDWARDSell10.80K$3.4036.72K
2025-06-13Stuglik Brian MSell8.10K$3.3927.46K
2025-06-13Senderowicz AdrianSell27.00K$3.4091.80K
2025-06-13MOYES JAY MSell22.00K$3.4074.80K
2025-06-13Dorval AllisonSell11.61K$3.4039.47K
2025-06-13Cesano AlessandraSell12.15K$3.4041.31K
2025-06-11MILLER MICHAEL PATRICKBuy27.00K——
2025-06-11Senderowicz AdrianBuy27.00K——
2025-06-11MOYES JAY MBuy27.00K——
2025-06-11Dorval AllisonBuy27.00K——
2025-06-11Stuglik Brian MBuy27.00K——
2025-06-11WILSON TROY EDWARDBuy27.00K——
2025-06-11Cesano AlessandraBuy27.00K——
2025-02-07NOUGUES MAXIMO FBuy61.46K——
2025-02-07NOUGUES MAXIMO FBuy85.07K$2.78236.49K
2025-02-07Ludwig Jeffrey JeromeBuy47.84K——
2025-02-07Ludwig Jeffrey JeromeBuy66.22K$2.78184.09K
2025-02-07HUNT DOUGLAS MBuy48.12K——
2025-02-07HUNT DOUGLAS MBuy66.60K$2.78185.16K
2025-02-07AUERBACH ALAN HBuy198.40K——
2025-02-07AUERBACH ALAN HBuy274.62K$2.78763.45K
2025-01-02NOUGUES MAXIMO FSell10.23K$3.1532.23K
2025-01-02Ludwig Jeffrey JeromeSell9.44K$3.1529.74K
2025-01-02HUNT DOUGLAS MSell8.63K$3.1527.21K
2025-01-02AUERBACH ALAN HSell33.84K$3.15106.66K
2024-08-12MILLER MICHAEL PATRICKSell23.36K$3.4981.47K
2024-07-17NOUGUES MAXIMO FSell4.16K$3.7015.38K
2024-07-17Ludwig Jeffrey JeromeSell2.60K$3.709.62K
2024-07-17HUNT DOUGLAS MSell3.64K$3.7013.46K
2024-07-17AUERBACH ALAN HSell21.92K$3.7081.13K
2024-07-02NOUGUES MAXIMO FSell5.29K$3.2717.31K
2024-07-02Ludwig Jeffrey JeromeSell6.05K$3.2719.78K
2024-07-02HUNT DOUGLAS MSell4.35K$3.2714.21K
2024-07-02AUERBACH ALAN HSell18.89K$3.2761.73K
2024-06-18WILSON TROY EDWARDBuy27.00K——
2024-06-18Stuglik Brian MBuy27.00K——
2024-06-18Senderowicz AdrianBuy27.00K——
2024-06-18MILLER MICHAEL PATRICKBuy27.00K——
2024-06-18MOYES JAY MBuy27.00K——
2024-06-18Dorval AllisonBuy27.00K——
2024-06-18Cesano AlessandraBuy27.00K——
2024-06-13WILSON TROY EDWARDSell27.00K$3.3389.90K
2024-06-13Stuglik Brian MSell9.90K$3.3933.53K
2024-06-13Senderowicz AdrianSell27.00K$3.3389.82K
2024-06-13MOYES JAY MSell22.00K$3.3473.47K
2024-06-13Dorval AllisonSell11.00K$3.3737.10K
2024-03-15AUERBACH ALAN HBuy6.58K——
2024-03-15AUERBACH ALAN HBuy9.05K$5.0045.23K
2024-02-12Wong Alvin FBuy43.31K——
2024-02-12Wong Alvin FBuy59.95K$6.36381.26K
2024-02-12NOUGUES MAXIMO FBuy43.31K——
2024-02-12NOUGUES MAXIMO FBuy59.95K$6.36381.26K
2024-02-12Ludwig Jeffrey JeromeBuy27.07K——
2024-02-12Ludwig Jeffrey JeromeBuy37.47K$6.36238.28K
2024-02-12AUERBACH ALAN HBuy160.80K——
2024-02-12AUERBACH ALAN HBuy222.57K$6.361.42M
2024-02-12HUNT DOUGLAS MBuy37.89K——
2024-02-12HUNT DOUGLAS MBuy52.45K$6.36333.59K
2024-01-03Wong Alvin FSell7.73K$4.4934.69K
2024-01-03Ludwig Jeffrey JeromeSell12.96K$4.4958.12K
2024-01-03AUERBACH ALAN HSell41.40K$4.49185.70K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 166, holders +7 vs prior quarter. Ownership 76.19%.

HolderSharesChangeChange %Value
ACORN CAPITAL ADVISORS, LLC4.13M00.00%33.50M
BLACKROCK, INC.3.80M205.78K+5.72%30.86M
AMERICAN CENTURY COMPANIES INC2.32M403.65K+21.06%18.82M
ACADIAN ASSET MANAGEMENT LLC2.05M11.76K+0.58%16.65M
RENAISSANCE TECHNOLOGIES LLC1.84M-106.20K-5.47%14.89M
VANGUARD CAPITAL MANAGEMENT LLC1.84M17.96K+0.99%14.89M
VANGUARD PORTFOLIO MANAGEMENT LLC1.83M90.95K+5.24%14.81M
LSV ASSET MANAGEMENT1.62M435.11K+36.78%13.12M
DIMENSIONAL FUND ADVISORS LP1.52M81.91K+5.70%12.31M
GEODE CAPITAL MANAGEMENT, LLC1.34M322.06K+31.66%10.86M
O'SHAUGHNESSY ASSET MANAGEMENT, LLC1.12M-14.39K-1.26%9.11M
STATE STREET CORP952.16K34.58K+3.77%7.72M
KENNEDY CAPITAL MANAGEMENT LLC873.25K-16.35K-1.84%7.08M
BRIDGEWAY CAPITAL MANAGEMENT, LLC791.62K16.27K+2.10%6.42M
RITHOLTZ WEALTH MANAGEMENT749.80K-24.51K-3.17%6.08M
AQR CAPITAL MANAGEMENT LLC725.19K-75.00K-9.37%5.88M
GOLDMAN SACHS GROUP INC669.16K-563-0.08%5.43M
NORTHERN TRUST CORP652.39K10.63K+1.66%5.29M
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.642.95K-139.85K-17.87%5.21M
UBS GROUP AG636.76K102.53K+19.19%5.16M
MILLENNIUM MANAGEMENT LLC602.24K-875.28K-59.24%4.88M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP532.45K-5.71K-1.06%4.32M
SEI INVESTMENTS CO418.67K-89.51K-17.61%3.40M
GLOBEFLEX CAPITAL L P382.81K33.16K+9.48%3.10M
BANK OF NEW YORK MELLON CORP360.73K12.85K+3.69%2.93M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Puma Biotechnology (PBYI) Stock Insights

PBYI$10.66-0.26 -2.38%

$550.27M

Market Cap

20.15

P/E

28.05

Forward P/E

45

Score

Price History